Zealand Pharma A/S (CPH:ZEAL)
238.00
+1.00 (0.42%)
Oct 9, 2026, 4:59 PM CET
Zealand Pharma Employees
Zealand Pharma had 578 employees as of June 30, 2026. The number of employees increased by 154 or 36.32% compared to the same quarter last year. That makes Zealand Pharma the 19,008th largest employer in the world and 56th in Denmark.
Employees
578
Change
154
Growth
36.32%
Revenue / Employee
8.03M DKK
Profits / Employee
4.74M DKK
Market Cap
16.21B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 578 | 154 | 36.32% | 578 | 0 |
| Mar 31, 2026 | 544 | 159 | 41.30% | 544 | 0 |
| Dec 31, 2025 | 501 | 146 | 41.13% | 481 | 20 |
| Sep 30, 2025 | 440 | 142 | 47.65% | 440 | 0 |
| Jun 30, 2025 | 424 | 136 | 47.22% | 424 | 0 |
| Mar 31, 2025 | 385 | 115 | 42.59% | 385 | 0 |
| Dec 31, 2024 | 355 | 102 | 40.32% | 335 | 20 |
| Sep 30, 2024 | 298 | 49 | 19.68% | 298 | 0 |
| Jun 30, 2024 | 288 | 52 | 22.03% | 288 | 0 |
| Mar 31, 2024 | 270 | 50 | 22.73% | 270 | 0 |
| Dec 31, 2023 | 253 | 57 | 29.08% | 253 | 0 |
| Sep 30, 2023 | 249 | 46 | 22.66% | 249 | 0 |
| Jun 30, 2023 | 236 | -1 | -0.42% | 236 | 0 |
| Mar 31, 2023 | 220 | -125 | -36.23% | 220 | 0 |
| Dec 31, 2022 | 196 | -159 | -44.79% | 196 | 0 |
| Sep 30, 2022 | 203 | -143 | -41.33% | 203 | 0 |
| Jun 30, 2022 | 237 | -98 | -29.25% | 237 | 0 |
| Mar 31, 2022 | 345 | 10 | 2.99% | 345 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 66,700 |
| Demant | 26,616 |
| Coloplast | 17,213 |
| GN Store Nord | 7,744 |
| Ambu A/S | 5,200 |
| H. Lundbeck | 5,000 |
| Embla Medical | 4,500 |
| Genmab | 3,119 |
Zealand Pharma News
- 1 day ago - Zealand Pharma (ZLDPF) Reports Promising Phase 2 Trial Results for Petrelintide in Type 2 Diabetes - GuruFocus
- 2 days ago - Zealand Reports Improved Weight Reduction With Petrelintide In Phase 2 ZUPREME-2 Study - Nasdaq
- 2 days ago - Zealand, Roche's obesity drug helps patients lose up to 9.2% weight in mid-stage trial - Reuters
- 9 days ago - Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts - Finanz Nachrichten
- 9 days ago - Zealand Pharma opens research hub in Cambridge, Massachusetts - TheFly
- 9 days ago - Zealand Pharma slides as concerns over patients quitting survodutide trials resurface - Reuters
- 9 days ago - Zealand Pharma: Boehringer's Survodutide Delivers Up To 13.1% Weight Loss In Phase 3 - Nasdaq
- 9 days ago - Zealand Pharma: Boehringer's Survodutide Meets Phase 3 Endpoints In Obesity & Diabetes Trial - Nasdaq